Dexrazoxane for preventing anthracycline cardiotoxicity in children with solid tumors.

Journal of Korean medical science

Volumn 25, Issue 9, 2010, Pages 1336-1342

  Choi, Hyoung Soo ^a   Park, Eun Sil ^b   Kang, Hyoung Jin ^b   Shin, Hee Young ^b   Noh, Chung Il ^b   Yun, Yong Soo ^b   Ahn, Hyo Seop ^b   Choi, Jung Yun ^b  

^a Seoul National University Bundang Hospital   (South Korea)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC ANTIBIOTIC; CARDIOVASCULAR AGENT; DOXORUBICIN; RAZOXANE;

ADOLESCENT; ARTICLE; CARDIOMYOPATHY; CHEMICALLY INDUCED DISORDER; CHILD; CLINICAL TRIAL; COHORT ANALYSIS; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE FREE SURVIVAL; ECHOCARDIOGRAPHY; FEMALE; FOLLOW UP; HEART FAILURE; HEART LEFT VENTRICLE FUNCTION; HUMAN; INFANT; MALE; MORTALITY; NEOPLASM; PHYSIOLOGY; PRESCHOOL CHILD;

ADOLESCENT; ANTIBIOTICS, ANTINEOPLASTIC; CARDIOMYOPATHIES; CARDIOVASCULAR AGENTS; CHILD; CHILD, PRESCHOOL; COHORT STUDIES; DISEASE-FREE SURVIVAL; DOXORUBICIN; ECHOCARDIOGRAPHY; FEMALE; FOLLOW-UP STUDIES; HEART FAILURE; HUMANS; INFANT; MALE; NEOPLASMS; RAZOXANE; VENTRICULAR FUNCTION, LEFT;

MLCS; MLOWN;

EID: 77957375770     PISSN: None     EISSN: 15986357     Source Type: Journal    
DOI: 10.3346/jkms.2010.25.9.1336     Document Type: Article

References (0)